机构:[1]Department of Orthopaedics and Traumatology, Stem Cells and Regenerative Medicine Laboratory, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.[2]Orthopaedic Center, Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang, China.[3]Lingnan Medical Research Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.[4]Department of Orthopaedic Surgery, School of Medicine, Stanford University, Stanford, CA, United States.
This work was partially supported by grants from the
National Natural Science Foundation of China (81874000 &
81772322); University Grants Committee, Research Grants
Council of the Hong Kong Special Administrative Region,
China (14120118, 14108720, C7030-18G, T13-402/17-N and
AoE/M-402/20); Hong Kong Innovation Technology
Commission Funds (PRP/050/19FX); Hong Kong Medical
Research Funds (16170951 and 17180831). This study
received support from the research funds from the Health@
InnoHK program launched by the Innovation Technology
Commission of the Hong Kong SAR, PR China
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|2 区医学
小类|2 区药学
最新[2025]版:
大类|3 区医学
小类|3 区药学
第一作者:
第一作者机构:[1]Department of Orthopaedics and Traumatology, Stem Cells and Regenerative Medicine Laboratory, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.[2]Orthopaedic Center, Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang, China.
通讯作者:
推荐引用方式(GB/T 7714):
Zong Zhixian,Xu Liangliang,Zhang Ning,et al.Editorial: Recent trends in pharmacological treatment of musculoskeletal disorders[J].Frontiers in pharmacology.2022,13:908977.doi:10.3389/fphar.2022.908977.
APA:
Zong Zhixian,Xu Liangliang,Zhang Ning,Cheung Wing-Hoi,Li Gang&Lin Sien.(2022).Editorial: Recent trends in pharmacological treatment of musculoskeletal disorders.Frontiers in pharmacology,13,
MLA:
Zong Zhixian,et al."Editorial: Recent trends in pharmacological treatment of musculoskeletal disorders".Frontiers in pharmacology 13.(2022):908977